After 11 years working at the University of Washington and the Fred Hutchinson Cancer Research Center, Dr. Mâsse moved back to Canada in August of 2010 and took a faculty appointment at the Université de Montreal as well as joining the Research Center at CHU-Ste-Justine. Overall, he has contributed to 85+ research grants since graduating in biostatistics from UNC-Chapel Hill in 1993. In addition to studies focused on HIV/AIDS, he has been involved in clinical trials and studies on children delinquent behavior; perinatal research; head and neck cancer chemoprevention; breast cancer; psychosocial and work environment studies on cardiovascular diseases, urinary infection, delirium in cancer palliative care, and pain management in early termination of pregnancy.
Dr. Mâsse has conducted multi-country large international trials in USA, Brazil, Canada, China, India, Russia, and in many countries of Africa. Since 2000, he has contributed to the research agenda of several large NIH networks by providing methodological support for the development of study protocols as well as providing the infrastructure to support the conduct of these studies. In 2006, Dr. Mâsse received a grant of over $US 25 millions from the NIH as the Principal Investigator responsible for establishing the Statistical Data Management Center for providing support to all international Phase I-II-III trials and observational studies conducted within the Microbicide Trials Network.
David Meyre, Tier II Canada Research Chair in Genetic Epidemiology, McMaster University (having come from the Institut de Biologie de Lille in France). Associate Professor in the Department of Clinical Epidemiology & Biostatistics.
Associate Professor of Economics at the H. Wayne Huizenga School of Business and Entrepreneurship at Nova Southeastern University.
Dr. Nguyen is a Principal Fellow and Lab Head of the Garvan Institute of Medical Research (Australia). He also holds joint appointments as Professor, St Vincent's Clinical School, University of New South Wales (UNSW Sydney); Professor of Predictive Medicine at the University of Technology Sydney (UTS); and conjoint Professor of Epidemiology and Biostatistics at the School of Medicine, University of Notre Dame Australia.
Corey Nislow's laboratory develops and uses cutting edge tools to address this central question: how can we understand the biological commonalities in all of the life sciences; from embryonic development, to the spread of infectious diseases to better ways to treat cancer. Each of these disciplines can be explained in the context of competition, interaction and evolution. His lab studies the interface between genes and the environment using parallel genome-wide screens, high throughput cell-based assays and next generation sequencing. Most recently, he and his scientific partner, Dr. Guri Giaever, are exploring how laboratory experiments can co-opt evolutionary processes to understand drug action. He enjoys teaching all aspects of biotechnology, genomics and drug discovery. He got his PhD from the University of Colorado, worked at several Biotechnology companies and was at Stanford and University of Toronto before joining UBC in 2013. He has published 161 papers and run 19 marathons.
I am a member of the Agents, Interaction and Complexity group, part of the Faculty of Physical and Applied Sciences at the University of Southampton, UK. I have a long-standing interest in using agent-based models to look at the evolution of social behaviour; I'm particularly interested in communication and social learning.
I am a Professor in Biostatistics and Clinical Research Methodology in the Department of Clinical Medicine at the Miguel Hernández University (Spain).
My research is focused on biostatistics, clinical research methodology, cardiovascular diseases and pediatrics.
I am a behavior change professional on the cross-section between behavior change science (psychology), methodology and statistics and technology (ICT).
Main interests include: behavior change, statistics, methodology, online research methodology and intervention development.
I am currently the director of the UC Davis Genome Center Proteomics Core and I am on the Executive board of the Association of Biomolecular Resource Facilities (www.abrf.org). I obtained my Ph D. in Biology studying viral protein structure using mass spectrometry and did a Post-doc with the noted Mass Spectrometrist Jack Watson at Michigan State University before founding the Proteomics Core there and becoming the co-director of the Michigan State Proteome Consortium
Fenna Diemer Lindenbaum Chair in Statistical Genetics; VU University & VU University Medical Centre, Amsterdam, The Netherlands; Executive Board Member Dutch IPSc Center; Director of Genetic Cluster Computer; Elected Member Young Academy of Netherlands Royal Society of Arts and Sciences.
Dr. Qin is currently an Associate Professor in the Department of Biostatistics and Bioinformatics at Rollins School of Public Health, Emory University. He is also a faculty member at the Department of Biomedical Informatics, Emory University School of Medicine. Dr. Qin received his B.S. degree in Probability and Statistics from Peking University in 1994 and Ph.D. degree in Statistics from University of Michigan in 2000. He was a postdoctoral fellow in Dr. Jun Liu’s group in Department of Statistics at Harvard University from 2000 to 2003. He joined the Department of Biostatistics at University of Michigan in 2003. In 2010, he moved to his current position in Emory University. Dr. Qin has more than 15 years of experience in statistical modeling and statistical computing with applications in statistical genetics and genomics. Recently, his research is focused on developing Bayesian model-based methods to analyze data generated from applications of next generation sequencing technologies such as ChIP-seq, RNA-seq and resequencing. Dr. Qin also actively collaborates with biomedical scientists and clinicians on various projects that utilizing next generation sequencing technologies to study cancer genomics. Dr. Qin has published more than 100 peer-reviewed research papers covering statistics, bioinformatics, statistical genetics and computational biology. He has supervised more than 10 graduate students and postdoctoral fellows.
Born in Bogotá Colombia on 3 August 1970. Currently Vice President for Research Universidad de los Andes, Bogotá. Professor at Los Andes University, Faculty of Sciences, Department Biological Sciences, Bogotá. Director of the Mycology and Plant Pathology laboratory, Universidad de los Andes Specialist on fungal diseases of plants molecular, population genetics, epidemiology, and control. Prof. Restrepo has been working in research and control of plant diseases in the last 20 years. Member of the Colombian Academy of Sciences.
Awarded the prizes TWAS, Christiane Doré, Elizabeth Grose and Louis Malassis
Keywords: Plant Pathology, fungi and oomycetes, epidemiology, population genetics, bioinformatics, genomics.